Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
DISCO Pharmaceuticals Logo
DISCO Pharmaceuticals Growth Score
79
CB Rank
20803
Heat Score
28
DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Founded
obfuscation
PrivateSeed Cologne, Nordrhein-Westfalen, Germany11-50 discopharma.de
Manufacturing
Pharmaceutical
Therapeutics
Overview

DISCO Pharmaceuticals
Total Funding
obfuscation
Growth Score
79
Heat Score
28

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score79
-14 pts
in past quarter
Heat Score 28
-33 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About DISCO Pharmaceuticals

CB Rank
20803
DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Founded
obfuscation
PrivateSeed Cologne, Nordrhein-Westfalen, Germany11-50 discopharma.de
Manufacturing
Pharmaceutical
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

  • Photo of Roman Thomas
    Roman Thomas: Strategic Advisor
    Past Role: Centessa Pharmaceuticals, Founder
  • Photo of Mark Manfredi
    Mark Manfredi: Chief Executive Officer
    Past Role: Ikena Oncology, President and CEO

Details

Legal Name DISCO Pharmaceuticals GmbH
Also Known As Disco
Operating Status Active
Company Type For Profit
About the Company
DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Contact Email info@discopharma.de
Predictions & Insights

Growth Insight

See this Growth Insight
DISCO Pharmaceuticals is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Surfaceome Mapping Platform
A technology platform that comprehensively maps the cancer cell surface to identify proteins and protein communities as drug targets.
Small Cell Lung Cancer (SCLC) Discovery Program
A research program focused on mapping the surfaceome of Small Cell Lung Cancer to identify novel therapeutic targets.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
6
obfuscation
Ackermans & van Haaren, NRW.BANKSeed
obfuscation
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
6
obfuscation
Ackermans & van Haaren, NRW.BANKSeed
obfuscation
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
6
obfuscation
Ackermans & van Haaren, NRW.BANKSeed
obfuscation
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
6
obfuscation
Ackermans & van Haaren, NRW.BANKSeed
obfuscation
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
6
obfuscation
Ackermans & van Haaren, NRW.BANKSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
6
obfuscation
Ackermans & van Haaren, NRW.BANKSeed
obfuscation
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
6
obfuscation
Ackermans & van Haaren, NRW.BANKSeed
obfuscation
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
6
obfuscation
Ackermans & van Haaren, NRW.BANKSeed
obfuscation
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
6
obfuscation
Ackermans & van Haaren, NRW.BANKSeed
obfuscation
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
6
obfuscation
Ackermans & van Haaren, NRW.BANKSeed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
M Ventures Logo
M Ventures
—
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
—
M Ventures Logo
M Ventures
—
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
—
M Ventures Logo
M Ventures
—
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
—
M Ventures Logo
M Ventures
—
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
—
M Ventures Logo
M Ventures
—
Seed Round - DISCO Pharmaceuticals Logo
Seed Round - DISCO Pharmaceuticals
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Board Members and Advisors 3 Contacts 4

Employee Profiles

Board Members and Advisors

News

News and Press

News•Feb 6, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

406
-20.55%
 in past month

IT Spend

$332.1KThis year, DISCO Pharmaceuticals is projected to spend $332.1K on IT, according to Aberdeen.

Active Website Tech Count

3DISCO Pharmaceuticals is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, Mobile Non Scaleable Content, and  CommonCrawl Top 5m.

Total IP

4DISCO Pharmaceuticals has registered 4 trademarks with the most popular class being 'Chemical substances', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is DISCO Pharmaceuticals's headquarters? DISCO Pharmaceuticals is located in Cologne, Nordrhein-Westfalen, Germany.Who invested in DISCO Pharmaceuticals? DISCO Pharmaceuticals has 6 investors including M Ventures and  Ackermans & van Haaren.When was the last funding round for DISCO Pharmaceuticals? DISCO Pharmaceuticals closed its last funding round on
obfuscation
from a Seed round.Who are DISCO Pharmaceuticals's competitors? Alternatives and possible competitors to DISCO Pharmaceuticals may include Emulate, Seismic Therapeutic, and  Foghorn Therapeutics.How much funding has DISCO Pharmaceuticals raised to date? DISCO Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(250d0b0 1)
|